| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |